Navigation Links
Intradigm Receives Notice of Allowance for Key RNA Interference (RNAi) Patent Covering Potent siRNA Sequence
Date:3/17/2009

Issuance Will Give Company Patents in Each of the Three Critical Areas of RNAi Therapeutic Development

PALO ALTO, Calif., March 17 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced that the United States Patent and Trademark Office (USPTO) has issued the company a notice of allowance for a patent covering various aspects of a potent small interfering RNA (siRNA) sequence. The allowed subject matter covers a specific double-stranded siRNA sequence that is directed against the angiogenic pathway and which possesses therapeutic potential in the treatment of cancer. This notice of allowance pertains to the first of a number of pending patent applications covering proprietary Intradigm siRNA sequences against more than 50 clinically relevant targets.

As the first sequence-specific patent for which Intradigm has received a notice of allowance, this development supplements the company's existing patents, giving Intradigm allowed intellectual property (IP) covering each of the three critical areas for RNAi therapeutic development: target sequences, delivery and structural features. This breadth of intellectual property places Intradigm in a uniquely strong position within the RNAi therapeutic industry, especially among other private companies in the space.

"The receipt of this notice of allowance provides us a great deal of confidence in our ability to successfully prosecute our large number of pending sequence patents and, in turn, build one of the industry's strongest siRNA sequence patent positions," said Philip Haworth, chief executive officer of Intradigm. "Additionally, once this patent issues, Intradigm will possess issued patents related to siRNA sequences, siRNA delivery technology and siRNA structural motifs. We believe this breadth of coverage provides the company with a key competitive advantage in the RNAi the
'/>"/>

SOURCE Intradigm Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Intradigm Closes Final Tranche of $21.4 Million Series B Financing
2. Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics
3. Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
4. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
5. Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome
6. Catilin Receives Renewable Energy Award for Pilot Plant
7. Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System
8. S*BIO Receives BioSpectrum Editors Choice, Emerging BioScience Company of Singapore Award
9. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
10. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
11. Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Dr. Kerry Solomon announced that ...launched his redesigned website at www.DrKerrySol...ng Group. Dr. Solomon is a proven LASIK, lens imp...fessionally recognized for his substantial contrib... is a member of Trusted LASIK Surgeons, which scre...
(Date:12/1/2009)..., PLYMOUTH, Mass., Dec. 1 Harvest...ced today results from the company sponsored 60-pa...Medical Center in Chennai, India using the company...uctable Critical Limb Ischemia (CLI). Sri Ramachan...nal-associated institution based in Chennai, India...
(Date:12/1/2009)... , SPRINGFIELD, Ill., Dec. 1 Pr... to announce that it was recently awarded two stat...ent on Nov. 13 in New York City. The CLIO Healthca...ation in the healthcare advertising industry and i...d,s most recognized awards competitions for advert...
(Date:12/1/2009)..., CRANBURY, N.J., Dec. 1 /PRNewswire-FirstCall/ -...day announced that the U.S. Patent and Trademark O... "Cyclic Natriuretic Peptide Constructs." The cla...compounds that bind to natriuretic peptide recepto...t failure drug candidate. ,, "Our natriuretic c...
Breaking Biology Technology:Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3
...il, successfully launches OmegaGen(... 25 /PRNewswire-FirstCall/ - Neptune Technologies ...X.V.NTB) and its commercial,pharmaceutical partner...ful,launch of OmegaGen(R) as a complementary medic... this market entry as a commercial portal for,Nept...
...:,MASI), the inventor of Pulse CO-Oximetry and Mea...ry, today announced an agreement with,Switzerland-...d supplier of,electrocardiographs, spirometers, pa...egrate the Masimo Rainbow SET technology platform ...heir patient monitoring,solutions worldwide., Mas...
...gy over competitors for its ease of use...DMOND, Wash., March 25 Microsoft Corp.,today anno...Dynamics AX 4.0,to speed and integrate its busines...liance with the Sarbanes-Oxley Act and with the re...luding the Food and Drug,Administration (FDA) and ...
Other Biology Technology:Neptune Technologies expands into medicinal markets in Asia Pacific 2Neptune Technologies expands into medicinal markets in Asia Pacific 3Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 2Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 3Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 4Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 5Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 2Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 3Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 4Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 5
(Date:12/2/2009)... the University of Salamanca and another from Yale...ors affects the behaviour of Acanthodactylus beer... in the Near East. According to the study, these r...ent prey if they are under pressure from predators...esult, but until now there had been very few exper...
(Date:12/1/2009)... Yerkes National Primate Research Center, Emory Un...ansgenic prairie voles, an important step toward u... future application of this technology will enable...ions that will help identify the brain mechanisms ...rs. This advancement may also have important impli...
(Date:12/1/2009)...vailable in German . , Brown adipose tissue i... of mitochondria, miniature power stations which ...they normally generate a voltage similar to that o...ar processes. However, the mitochondria of brown f...ahead all the time. The energy released when the f...
Breaking Biology News(10 mins):Lizards change their diet to avoid predators 2Yerkes researchers create first transgenic prairie voles 2Brown fat cells make 'spare tires' shrink 2Greenway Medical Technologies Supports Community Based Interoperability Efforts by Offering Preferred Rates to Buffalo N Y Area Community Healthcare 49912 1Greenway Medical Technologies Supports Community Based Interoperability Efforts by Offering Preferred Rates to Buffalo N Y Area Community Healthcare 49912 2Greenway Medical Technologies Supports Community Based Interoperability Efforts by Offering Preferred Rates to Buffalo N Y Area Community Healthcare 49912 3World renowned nanotechnology expert proves there is big potential in the smallest of matter 49908 1World renowned nanotechnology expert proves there is big potential in the smallest of matter 49908 2World renowned nanotechnology expert proves there is big potential in the smallest of matter 49908 3World renowned nanotechnology expert proves there is big potential in the smallest of matter 49908 4Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 1Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 2Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 3Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 4
...MARCH 2009 More than 120 researchers will speak a...ences conference to be organized by the European M...msterdam from 29 August to 1 September 2009. , T...rough broad programmes reflecting the concepts and...esearch. It follows on from former ELSO meetings t...
...n are fertile throughout life, but research at the...eden, has now shown that a fertilising sperm can g...an important step towards future stem cell therapy...foetus is highly correlated to the age of the moth...ther. One possible explanation is that egg cells h...
..., 2009 - Critically endangered hawksbill turtles a...e Dominican Republic after a powerful government c...ch items. More than 99 percent of these souvenirs ...ade monitoring network TRAFFIC reports. , A 2006...000 items made from hawksbill turtles for sale. A ...
Other Biology News:Call for abstracts and registration for the EMBO Meeting 2009 2Turtles no longer turned into souvenirs 2
Goat Anti-FBXO2 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Dardarin Antibody, Unconjugated from CHEMICON
Rat Anti-Gamma delta T Lymphocytes Monoclonal Antibody, Unconjugated, Clone MAC320 from BD Biosciences Pharmingen
LC/MSD TOF from Agilent Technologies
Biology Products: